Breaking News

Syner-G BioPharma Acquires RMC Pharma Solutions

Provides additional pharmaceutical science services, adding development experience in all biologic modalities including cell and gene therapy.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Syner-G BioPharma Group, a provider of pharmaceutical science and regulatory consulting services, has acquired RMC Pharmaceutical Solutions (RMC). RMC supports the outsourced CMC and Quality needs of biotech and pharma companies across multiple therapeutic areas. Financial terms were not disclosed.   The acquisition provides additional pharmaceutical science services, adding development experience in all biologic modalities including cell and gene therapy. The combined team offers a range of p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters